Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study炎症性肠病患者经剂量强化后肿瘤坏死因子拮抗剂降级治疗的成功率及预测因素:一项希腊-土耳其真实世界合作研究EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGYIF1.82026-01-010PRE
The Inflammatory Bowel Disease-Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek VersionJOURNAL OF CLINICAL MEDICINEIF2.92023-04-213OAAI
The natural history of COVID-19 in vaccinated inflammatory bowel disease patientsDIGESTIVE AND LIVER DISEASEIF3.82023-03-010OAAI
Maintenance of deep remission in Crohn's disease after switching from anti-TNF to ustekinumabJOURNAL OF CROHNS & COLITISIF8.72021-05-271PRE
Which patients with known Crohn's disease after an ileo-colonoscopy will benefit most from small bowel capsule endoscopy?JOURNAL OF CROHNS & COLITISIF8.72021-05-270OA
Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitisJOURNAL OF CROHNS & COLITISIF8.72019-01-250OAAI
FREQUENCY AND PREDICTORS OF NO TREATMENT IN ANTI-HCV POSITIVE PATIENTS AT TERTIARY LIVER CENTERSJOURNAL OF HEPATOLOGYIF332011-03-010OAAI
The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's diseaseJOURNAL OF CROHNS & COLITISIF8.72007-09-018OA
Serum leptin concentrations in chronic viral hepatitis: A clinical approachJOURNAL OF HEPATOLOGYIF332007-04-010OAAI
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitisAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62004-06-01108PREAI
Budesonide Versus Mesalamine for Maintaining Remission in Patients Refusing Other Immunomodulators for Steroid-Dependent Crohn's DiseaseCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122003-03-0139OA